Wellington Management Group
EWTX icon

Wellington Management Group’s Edgewise Therapeutics EWTX Stock Holding History

Wellington Management Group’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$863K Sell
27,409
-83,978
-75% -$2.42M ﹤0.01% 1703
2025
Q4 		$2.76M Sell
111,387
-3,144
-3% -$63.1K ﹤0.01% 1521
2025
Q3 		$1.86M Buy
114,531
+1,961
+2% +$27.8K ﹤0.01% 1650
2025
Q2 		$1.48M Sell
112,570
-733
-0.6% -$10.6K ﹤0.01% 1646
2025
Q1 		$2.49M Sell
113,303
-89,590
-44% -$2.35M ﹤0.01% 1512
2024
Q4 		$5.42M Sell
202,893
-2,428
-1% -$77.3K ﹤0.01% 1332
2024
Q3 		$5.48M Sell
205,321
-288,526
-58% -$5.74M ﹤0.01% 1309
2024
Q2 		$8.89M Buy
493,847
+20,944
+4% +$365K ﹤0.01% 1183
2024
Q1 		$8.63M Buy
472,903
+131,997
+39% +$2.1M ﹤0.01% 1180
2023
Q4 		$3.73M Hold
340,906
– – ﹤0.01% 1370
2023
Q3 		$1.95M Hold
340,906
– – ﹤0.01% 1475
2023
Q2 		$2.64M Hold
340,906
– – ﹤0.01% 1425
2023
Q1 		$2.27M Hold
340,906
– – ﹤0.01% 1484
2022
Q4 		$3.05M Hold
340,906
– – ﹤0.01% 1400
2022
Q3 		$3.35M Hold
340,906
– – ﹤0.01% 1390
2022
Q2 		$2.71M Hold
340,906
– – ﹤0.01% 1483
2022
Q1 		$3.31M Sell
340,906
-340,906
-50% -$4.39M ﹤0.01% 1493
2021
Q4 		$10.4M Hold
681,812
– – ﹤0.01% 1246
2021
Q3 		$11.3M Sell
681,812
-59,776
-8% -$1.08M ﹤0.01% 1241
2021
Q2 		$15.5M Sell
741,588
-824
-0.1% -$22.5K ﹤0.01% 1159
2021
Q1 		$23.1M Buy
+742,412
New +$24.1M ﹤0.01% 1034

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wellington Management Group's EWTX Position: Q1 2026 in Review

Wellington Management Group reduced its Edgewise Therapeutics (EWTX) stake by 75% in Q1 2026, selling an estimated $2.42M and leaving 27,409 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

Wellington Management Group first reported a position in EWTX in Q1 2021 and has held it in 21 quarters since. The position peaked at $23.1M in Q1 2021. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Wellington Management Group held 27,409 shares of Edgewise Therapeutics worth $863K as of Q1 2026.
  • Wellington Management Group sold 83,978 Edgewise Therapeutics shares in Q1 2026, an estimated $2.42M.
  • Edgewise Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1703 holding.
  • Wellington Management Group first reported a position in Edgewise Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Wellington Management Group's Edgewise Therapeutics position peaked at $23.1M in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.